medigraphic.com
ISSN 1561-3194 (Electronic)

2019, Number 2

<< Back

Rev Ciencias Médicas 2019; 23 (2)

The application of Heberprot-P 75 in patients with Grade 3 Diabetic Foot

Miranda PR, González TM, Monzón TMJ, Pozo PD

Language: Spanish
References: 10
Page: 351-355
PDF size: 492.37 Kb.


ABSTRACT

Introduction: the Diabetic Foot is a clinical alteration of etiopathogenic-neuropathic base and induced by maintained hyperglycemia, with or without coexistence of ischemia, and previous traumatic trigger, produces injury and/or ulceration of the foot.
Case report presentation: a 44-year old, white race patient who came to the emergency room because several days ago he perforated the plantar region of the right foot with a metal nail, he referred not having sensitivity in the feet, he noticed the loss of blood, increased volume of the foot with change of color, that’s to say redness, increasing along the leg, as well as high fever of 39 degrees centigrade. The patient was admitted with the diagnosis of a Systemic Inflammatory Response Syndrome by a Grade 3 Diabetic Septic Foot in the Hospitalization Room and the treatment started.
Conclusions: it can be concluded that the application of the Heberprot-P showed satisfactory results reincorporating the patient to the social and working life, without physical limitations, and in a short period of time.


REFERENCES

  1. Standards of Medical Care in Diabetes. Diabetes Care[Internet]. 2016 [citado 25/10/2018];3 9(supl.1): s4-s5. Disponible en: https://doi.org/10.2337/dc16-S003

  2. Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K. Prevention and management of foot problems in diabetes: a Summary Guidance for Daily Practice 2015, based on the IWGDF Guidance Documents. Diabetes Metab Res Rev[Internet]. 2016[citado 25/10/2018]; 32(supll. 1): 7-15 Disponible en: https://onlinelibrary.wiley.com/doi/epdf/10.1002/dmrr.2695

  3. Feldman EL, McCulloch DK. Treatment of diabetic neuropathy. UpToDate. 2016. Disponible en: https://www.uptodate.com/contents/treatment-of-diabetic-neuropathy

  4. Verdú-Soriano J, Restrepo-Medrano JC. Desarrollo de un índice de medida de la evolución hacia la cicatrización de las heridas crónicas. Gerokomos [Internet]. 2011 Dic citado 25/10/2018] ; 22(4): 176-183. Disponible en: http://dx.doi.org/10.4321/S1134- 928X2011000400005

  5. Bus SA, Armstrong DG, van Deursen RW, Lewis JEA, Caravaggi CF, Cavanagh PR. “IWGDF guidance on footwear and offloading interventions to prevent and heal foot ulcers in patientswith diabetes”. Diabetes Metab Res Rev [Internet]. 2016[citado 25/10/2018]; 32(suppl.1): 25-36. Disponible en: https://onlinelibrary.wiley.com/doi/pdf/10.1002/dmrr.2697

  6. Nehring P, Makowski A, Mrozikiewicz-Rakowska B, Sobczyk-Kopcioł A, Płoski R, Karnafel W. Risk factors of diabetic foot of neuropathic origin in patients with type 2 diabetes. Endokrynolgia Poskal. [Internet]. 2015[citado 25/10/2018]; 66(1):10-4. Disponible en: https://www.researchgate.net/publication/273385883_Risk_factors_of_diabetic_foot_of_neu ropathic_origin_in_patients_with_type_2_diabetes

  7. García Herrera AL, Rodríguez Fernández R, Peña Ruiz VM, Rodríguez Hernández L, Acosta Cabadilla L, Febles Sanabria R, et al. El significado clínico del pie diabético. Análisis de 10 años. Rev Cubana Angiol Cir Vasc[Internet]. 2011 [citado 12/02/2014];12(1). Disponible en: http://bvs.sld.cu/revistas/ang/vol12_01_11/ang08111.htm

  8. Álvarez López A. Respuesta al tratamiento con Heberprot-P® según la severidad de la enfermedad arterial periférica. Rev Cubana Angiol Cir Vasc [Internet]. 2016 Dic [citado 25/10/2018] ; 17( 2 ): 130-137. Disponible en: http://scieloprueba.sld.cu/scielo.php?script=sci_arttext&pid=S1682- 00372016000200003&lng=es.

  9. García Herrera AL. El pie diabético en cifras. Apuntes de una epidemia. Rev.Med.Electrón. [Internet]. 2016 Ago [citado 25/10/2018]; 38( 4 ): 514-516. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242016000400001&lng=es

  10. Rodríguez Gurri D. Caracterización de los pacientes con pie diabético tratados con Heberprot-P® en el Hospital Militar de Holguín. Rev Cubana Angiol Cir Vasc. [Internet]. 2014 Jun [citado 25/10/2018] ; 15( 1 ): 39-46. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1682-00372014000100006&lng=es




2020     |     www.medigraphic.com